Observational, hypothesis-driven and genomics research strategies for analyzing inherited differences in responses to infectious diseases

Public Health Genomics

Volumn 12, Issue 1, 2008, Pages 41-52

  Allison, A C ^a  

^a Alavita Pharmaceuticals Inc   (United States)

Author keywords

Genes; Genomics; Hemoglobinopathy; Immunodeficiency; Infections; Resistance; Selection; Susceptibility

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; MICROSATELLITE DNA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

ADENOSINE DEAMINASE DEFICIENCY; AUTOSOMAL RECESSIVE DISORDER; B LYMPHOCYTE; BIOCHEMISTRY; CYSTIC FIBROSIS; GENE MUTATION; GENETIC POLYMORPHISM; GENOMICS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HAPLOTYPE; HEPATITIS B; HEPATITIS C; HETEROZYGOTE; HUMAN; HYPOTHESIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION; INFECTION RESISTANCE; INHERITANCE; LEUKOCYTE; MALARIA; MORTALITY; MUTATION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SICKLE CELL; T LYMPHOCYTE; X LINKED AGAMMAGLOBULINEMIA;

ADULT; ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC RESEARCH; GENOMICS; HUMANS; RESEARCH DESIGN;

PLASMODIUM FALCIPARUM;

EID: 68149160032     PISSN: 16624246     EISSN: None     Source Type: Journal    
DOI: 10.1159/000154817     Document Type: Review

References (77)

1. Comstock GW: Tuberculosis in twins: a re- analysis of the Prophit survey. Am Rev Respir Dis 1978;117:621-624.
2. Malaty HM, Engstrand L, Pedersen NL, Graham DY: Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med 1994; 120:982-986.
3. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW: Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988;318:727-732.
4. Casanova JL, Abel L: The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 2004;4: 1-13.
5. Bruton OC: Agammaglobulinemia. Pediaics 1952;9:722-728.
6. DiGeorge AM: A new concept of the cellular basis of immunity. J Pediatr 1965; 67: 907-908.
7. Frank MM: Complement deficiencies. Pedi- atr Clin North Am 2000;47:1339-1354.
8. Kostmann R: Infantile genetic agranulocytosis. Acta Pediatr Scand 1956;45:1-78.
9. Segal AW, Jones OT, Webster D, Allison AC: Absence of a newly described cytochrome from neutrophils of patients with chronic granulomatous disease. Lancet 1978; 2: 446-449.
10. Gsiblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ: Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 1972; 2: 1067-1069.
11. Giblett ER, Ammann AI, Wara DW, Sandman R, Diamond LK: Nucleosidephosphor- ylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet 1975;1:1010-1013.
12. Allison AC, Hovi T, Watts RW, Webster AD: Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de novo purine synthesis in lymphocyte transformation. Lancet 1975; 2: 11791183.
13. Allison AC, Almquist SJ, Muller CD, Eugui EM: In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. Transplant Proc 1991;23(suppl 2):10-14.
14. Tsukada S, Saffran DC, Rawlings DJ, Paro- lini O, Allen RC, Klisak I, Sparkes RS, Ku- bagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, Witte ON: Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;72:279-290.
15. Macchi P, Villa A, Giliani S, Sacco MG, Frat- tini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ, Vezzoni P, Notarange- lo L: Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995;377:65-68.
16. Segal AW, Heyworth PG, Cockcroft S, Bar- rowman MM: Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44,000 protein. Nature 1985;316:547- 549.
17. Morel F: Molecular aspects of chronic granulomatous disease: 'the NADPH oxidase complex'. Bull Acad Natl Med 2007; 191:377-390.
18. Tournamille C, Colin Y, Cartron JP, Le Van Kim C: Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995;10:224-228.
19. Miller LH, Mason SJ, Clyde DF, McGinniss MH: The resistance factor to Plasmodium vivax in blacks. The Duffy-blood group genotype, FyFy. N Engl J Med 1976; 295: 302-304.
20. Ryan JR, Stoute JA, Amon J, Dunton RF, Mtalib R, Koros J, Owour B, Luckhart S, Wirtz RA, Barnwell JW, Rosenberg R: Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am J Trop Med Hyg 2006; 75: 575-581.
21. Cavasini CE, Mattos LC, Couto AA, Couto VS, Gollino Y, Moretti LJ, Bonini-Domingos CR, Rossit AR, Castilho L, Machado RL: Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region. Malar J 2007; 19:157-172.
22. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, Huttley GA, Allikmets R, Schriml L, Ger- rard B, Malasky M, Ramos MD, Morlot S, Tzetis M, Oddoux C, di Giovine FS, Na- sioulas G, Chandler D, Aseev M, Hanson M, Kalaydjieva L, Glavac D, Gasparini P, Kana- vakis E, Claustres M, Kambouris M, Ostrer H, Duff G, Baranov V, Sibul H, Metspalu A, Goldman D, Martin N, Duffy D, Schmidtke J, Estivill X, O'Brien SJ, Dean M: Dating the origin of the CCR5-A32 AIDS-resistance al- lele by the coalescence of haplotypes. Am J Hum Genet 1998;62:1507-1515.
23. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, Koup RA: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-1243.
24. Lindesmith L, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, Vinje J, Baric RS: Human susceptibility and resistance to Norwalk virus infection. Nat Med 2008; 9: 548-553.
25. Ingram VM: Abnormal human hemoglobins III. The chemical difference between normal and sickle-cell hemoglobins. Biochim Bio- phys Acta 1959;25:402-411.
26. Allison AC: Protection afforded by the sickle-cell trait against subterian malaria infection. Br Med J 1954;1:290-294.
27. Allison AC: Aspects of polymorphism in man. Cold Spring Harbor Symp Quant Biol 1965;20:239-251.
28. May J, Evans JA, Timmann C, Ehmen C, Busch W, Thye T, Agbenyega T, Horst- mann RD: Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA 2007; 29: 2220-2226.
29. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, Nahlen BL, Lal AA, Udhayakumar V: Protective effects of the sickle-cell gene against malaria morbidity and mortality. Lancet 2002;359:1311- 1312.
30. Allison AC: The distribution of the sickle- cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subsection malaria. Trans R Soc Trop Med Hyg 1954; 48:312-318.
31. Allison AC: Two lessons from the interface of genetics and medicine. Genetics 2004; 166: 1591-1599.
32. Lapoumeroulie C, Dunda O, Duroco R, Traibychet G, Mony-Lobe M, Bodo JM, Car- nevale P, Labie D, Elion J, Krishnamoorthy R: A novel sickle-cell mutation of yet another origin in Africa: the Cameroon type. Hum Genet 1992; 89: 333-337.
33. Labie D, Srinivas R, Dunda O, Dode C, Lapoumerolie C, Devi V, Devi S, Ramasami K, Elion J, Ducrocq R: Haplotypes in tribal Indians bearing the sickle-gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of tribal populations in India. Hum Biol 1989;61:479-491.
34. Bianco I, Montalenti FG, Silvestroni E, Sinis- calco M: Further data on genetics of micro- cythaemia or thalassaemia minor and Coo- ley's disease or thalassaemia major. Ann Eugen 1952;16:299-315.
35. Flatz C: Hemoglobin E: distribution and population dynamics. Humangenetik 1967; 3:189-234.
36. Modlano D, Luoni G, Sirima BS, Simpore J, Verra F, Konate A, Rastrelli E, Olivieri A, Calissano C, Paganotti GM, D'Urbano L, Sa- nou I, Sawadogo A, Modiano G, Coluzzi M: Haemoglobin C protects against clinical P. falciparum malaria. Nature 2001; 414: 305-308.
37. Tishkoff S, Varkonyi R, Cahinian N, Abbes S, Argyropoulos G, Destro-Bisol G, Drou- siotou A, Dangerfield B, Lefranc G, Loiselet J, Piro A, Stoneking M, Tagarelli A, Tagarel- li G, Touma EH, Williams SM, Clark AG: Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 2001;293:455-462.
38. Allison AC, Clyde DF: Malaria in African children deficient in glucose-6-phosphate dehydrogenase. Br Med J 1961; 1:1546 -1549.
39. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, Newbold DI, Greenwood BM, Marsh K, Hill AVS: Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995; 378: 246-249.
40. Welsh MJ: Cystic fibrosis; in Goldman L, Bennett JC (eds): Cecil Textbook of Medicine, 21st edition. W.B. Saunders Company, 2000, vol 1, pp 401-405.
41. Knudson AG Jr, Wayne L, Hallett WY: On the selective advantage of cystic fibrosis het- erozygotes. Am J Hum Genet 1967; 19:388392.
42. Gabriel SE, Brigman FN, Koliste BH, Boucher RC, Stutts MJ: Cystic fibrosis heterozy- gote resistance to cholera toxin in the cystic fibrosis mouse model. Science 1994;266:107-109.
43. Cuthbert AW, Halstead J, Ratcliff R, Colledge WH, Evans MJ: The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J Physiol 1995;482:449-454.
44. Hogenauer C, Santa Ana CA, Porter JL, Mi- lard M, Gelfand A, Rosenblatt RL, Prestidge CB, Fordtran JS: Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am J Hum Genet 2000;67:1422-1427.
45. Pier GB, Grout M, Zaidi T, Meluleni G, Mue- schenborn SS, Banting G, Ratcliff R, Evans MJ, Colledge WH: Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 1998;392: 79-82.
46. Cargill M, Altshuler D, Ireland J, Sklar P,Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999;22: 232-238.
47. The International HapMap Consortium: The International HapMap Project. Nature 2003;426: 789-796.
48. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J: A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996;380:152-154.
49. Abel L, Dessein AJ: Genetic epidemiology of infectious diseases in humans: design of population-based studies. Emerg Infect Dis 1998; 4:593-603.
50. Feldmann M, Brennan FM, Maini RN: Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996;14:397-440.
51. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M: Mutations in two adjacent novel genes are associated with epider- modysplasia verruciformis. Nat Genet 2002; 32: 579-581.
52. Hernandez PA, Gorlin RJ, Lukens JN, Taniu- chi S, Bohinjec J, Francois F, Klotman ME, Diaz GA: Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 2003; 34:70-74.
53. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, Cahn AP, Durham J, Heath P, Wray P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw-Smith CJ, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, de St Basile G, Jones A, Behloradsky BH, Achatz H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley DR: Host response to EBV infection in X-linked lym- phoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998;20:129-135.
54. Plancoulaine S, Gessain A, van Beveren M, Tortevoye P, Abel L: Evidence for a recessive major gene predisposing to human herpesvirus 8 (HHV-8) infection in a population in which HHV-8 is endemic. J Infect Dis 2003; 187:1944-1950.
55. Plancoulaine S, Gessain A, Joubert M, Tortevoye P, Jeanne I, Talarmin A, de The G, Abel L: Detection of a major gene predisposing to human T lymphotropic virus type I infection in children among an endemic population of African origin. J Infect Dis 2000; 182: 405-412.
56. Hoffmann JA: The immune response of Drosophila. Nature 2003;426:33-38.
57. Beutler B, Rietschel ET: Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003;3:169-176.
58. Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
59. Zhang SY, Jouangay E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku CL, Casrouge A, Zhang XX, Barreiro L, Leonard J, Hamilton C, Lebon P, Heron B, Vallee L, Quintana-Murci L, Hov- nanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova JL: TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007;317:1522-1527.
60. Picard C, Puel A, Bonnet M, Ku CL, Busta- mante J, Yang K, Soudais C, Dupuis S, Fein- berg J, Fieschi C, Elbim C, Hitchcock R, Lammas D, Davies G, Al-Ghonaium A, Al- Rayes H, Al-Jumaah S, Al-Hajjar S, Al- Mohsen IZ, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkeji H, Haraguchi S, Day NK, Good RA, Gougerot-Pocidalo MA, Ozinsky A, Casanova JL: Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003; 99:2076-2079.
61. Isaacs A, Lindenmann J: Virus interference. I. The interferon. Proc R Soc London B Biol Sci 1957;147:258-267.
62. Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, Al-Jumaah S, Yang K, Chap- gier A, Eidenschenk C, Eid P, Al Ghonaium A, Tufenkeji H, Frayha H, Al-Gazlan S, Al- Rayes H, Schreiber RD, Gresser I, Casanova JL: Impaired response to interferon-alpha/ beta and lethal viral disease in human STAT1 deficiency. Nat Genet 2003; 33: 388-391.
63. Schofield L, Grau GE: Immunological processes in malaria pathogenesis. Nat Revs Immunol 2005; 5: 722-735.
64. Crowe JE, Sannella EC, Pfeiffer S, Zorn GL, Azimzadeh A, Newman R, Miller GG, Pier- son RN: CD154 regulates primate humoral immunity to influenza. Am J Transplant 2003;3: 687-688.
65. Sabeti P, Usen S, Farhadian S, Jallow M, Doherty T, Newport M, Pinder M, Ward R, Kwiatkowski D: CD40L association with protection from severe malaria. Genes Im- mun 2002; 3: 286-291.
66. Knight JC, Udalova I, Hill AV, Greenwood BM, Seshu N, Marsh K, Kwiatkowski D: A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999;22:145-150.
67. Kwiatkowski D: Genetic susceptibility to malaria getting complex. Curr Opin Genet Dev 2000;10: 320-324.
68. Hill AVS, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM: Common West African HLA antigens are associated with protection from severe malaria. Nature 1991;352:595-600.
69. Frodsham AJ, Hill AVS: Genetics of infectious diseases. Hum Mol Genet 2004; 13: R187-R194.
70. Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, Schaffner SF, Gabriel SB, Platko JV, Patterson NJ, McDonald GJ, Ackerman HC, Campbell SJ, Altshuler D, Cooper R, Kwiatkowski D, Ward R, Lander ES: Detecting recent positive selection in the human genome from haplotype structure. Nature 2002;419:832-837.
71. Tishkoff SA, Varkonyi R, Cahinian N, Abbes S, Argyropoulos G, Destro-Bisol G, Drou- siotou A, Dangerfield B, Lefranc G, Loiselet J, Piro A, Stoneking M, Tagarelli A, Tagarel- li G, Touma EH, Williams SM, Clark AG: Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 2001; 293: 455-462.
72. Allison AC: Notes on sickle-cell polymorphism. Ann J Hum Genet 1954;19:39-57.
73. Jeffares DC, Pain A, Berry A, Cox AV, Stalker J, Ingle CE, Thomas A, Quail MA, Sieben- thall K, Uhlemann AC, Kyes S, Krishna S, Newbold C, Dermitzakis ET, Berriman M: Genome variation and evolution of the malaria parasite Plasmodium falciparum. Nat Genet 2007;39:120-125.
74. Mira MT, Alcais A, Van Thuc N, Thai VH, Huong NT, Ba NN, Verner A, Hudson TJ, Abel L, Schurr E: Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet 2003; 33: 412-415.
75. Siddiqui MR, Meisner S, Tosh K, Balakrish- nan K, Ghei S, Fisher SE, Golding M, Shan- ker Narayan NP, Sitaraman T, Sengupta U, Pitchappan R, Hill AV: A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet 2001;27:439-441.
76. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, Feingold J, Weissenbach J, Dessein AJ: Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996;14:181-184.
77. Dessein AJ, Hillaire D, Elwali NE, Marquet S, Mohamed-Ali Q, Mirghani A, Henri S, Abdelhameed AA, Saeed OK, Magzoub MM, Abel L: Severe hepatic fibrosis in Schistoso- ma mansoni infection is controlled by a major locus that is closely linked to the inter- feron-gamma receptor gene. Am J Hum Genet 1999;65:709-721